#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Monogenic diabetes Breast cancer Myelin oligodendrocyte glycoprotein antibody-associated disease Mucous membrane pemphigoid Cutaneous T-cell lymphoma stage I Anal squamous cell carcinoma Rhabdomyosarcoma recurrent Salivary gland cancer Behcet's syndrome Arteriosclerosis Transitional cell carcinoma Oesophageal atresia Retinoblastoma Follicular lymphoma stage III Systemic candida More trials…

    Learn about Rare Diseases

    Osteosarcoma metastatic – Treatment Glomerulonephritis membranous – Trials in Disease Short-bowel syndrome – Basic Information Factor IX deficiency – Trials in Disease Malignant fibrous histiocytoma – Treatment Glycogen storage disease type II – Trials in Disease Basal cell naevus syndrome Haemophilia A without inhibitors – Life with Disease Paroxysmal nocturnal haemoglobinuria – Diagnostics Mitochondrial myopathy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Autologous Microfat Ecoo1A Iomeprol Ro7247669 Tumor Necrosis Factor-Alpha Ttx-030 Bisacodyl Gs-5718-03 Tafasitamab Eletriptan Metamizole Sodium Monohydrate Evx-01 Masofaniten Clindamycin Hydrochloride Inupadenant Antiemetics And Antinauseants Magnesium Citrate Donepezil SKB410 Rbl015.2 More therapies…

    Learn about Your Condition

    Irritable bowel syndrome Rosai-Dorfman syndrome Krabbe's disease Gout Fibrosarcoma metastatic Nervous system disorder Hereditary optic atrophy Transferrin decreased Encephalopathy neonatal Noonan syndrome Myasthenia gravis Synovial sarcoma Ischaemic stroke Migraine Skin neoplasm excision More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Plasma cell myeloma

  • Study on Talquetamab and Tocilizumab for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Talquetamab
    • Tocilizumab
    Belgium France Germany The Netherlands Poland Spain

  • Study of Daratumumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Daratumumab
    • Dexamethasone Sodium Phosphate
    • Pomalidomide
    Italy

  • Study of Daratumumab with Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Dexamethasone Acetate
    • Bortezomib
    • Daratumumab
    Belgium Czechia Denmark France Germany Greece +5

  • Study of JNJ-68284528 for Treating Multiple Myeloma in Patients Using Ciltacabtagene Autoleucel and Drug Combination

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Ciltacabtagene Autoleucel
    • Dexamethasone Ph. Eur.
    • Bortezomib
    Belgium France Germany The Netherlands Spain

  • Study on Belantamab Mafodotin for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Belantamab Mafodotin
    France Germany Greece Ireland Italy Poland +1

  • Study Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    • Plasma cell myeloma
    Investigated Drugs:
    • Ciltacabtagene Autoleucel
    • Dexamethasone Ph. Eur.
    • Bortezomib
    Belgium Denmark France Germany Greece Italy +4
Previous Page
1 … 17 18 19 20 21 … 27
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!